[Value in heart failure proven again. AT II blocker soon also for post-infarct patients?].
出版信息
MMW Fortschr Med. 2003 Oct 23;145(43):51.
PMID:14664222
Abstract
摘要
相似文献
1
[Value in heart failure proven again. AT II blocker soon also for post-infarct patients?].
MMW Fortschr Med. 2003 Oct 23;145(43):51.
2
Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int. 2005 Oct;14(79):180-6.
3
[When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
MMW Fortschr Med. 2003 Dec 4;145(49):18-9.
4
Valsartan, captopril, or both in myocardial infarction.
N Engl J Med. 2004 Feb 26;350(9):943-5; author reply 943-5. doi: 10.1056/NEJM200402263500918.
5
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
J Am Coll Cardiol. 2006 Feb 21;47(4):726-33. doi: 10.1016/j.jacc.2005.09.055. Epub 2006 Jan 26.
6
[Successful mega studies with heart patients. Valsartan possesses cardioprotective action].
MMW Fortschr Med. 2006 Feb 2;148(5):48-9.
7
Valsartan, captopril, or both in myocardial infarction.
N Engl J Med. 2004 Feb 26;350(9):943-5; author reply 943-5.
8
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Am J Cardiol. 2009 Jul 15;104(2):151-7. doi: 10.1016/j.amjcard.2009.03.020. Epub 2009 Jun 3.
9
[New options against undertreatment].
MMW Fortschr Med. 2003 Dec 4;145(49):18.
10
Valsartan, captopril, or both in myocardial infarction.
N Engl J Med. 2004 Feb 26;350(9):943-5; author reply 943-5.
Zotero 插件